Dr. Ben Shields and Dr. Matt McCormack, Walter and Eliza Hall Institute (IMAGE)

Walter and Eliza Hall Institute

Dr. Ben Shields and Dr. Matt McCormack, Walter and Eliza Hall Institute

Caption

Researchers from the Walter and Eliza Hall Institute in Melbourne, Australia, have shown they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth. The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukaemia.

Credit

Walter and Eliza Hall Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.